Difference between revisions of "Category:Hedgehog pathway inhibitors"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "Category:Chemotherapy" to "Category:Chemotherapeutic") |
||
| Line 1: | Line 1: | ||
A class of drugs that target one or more components of the Hedgehog signaling pathway. Vismodegib is the first in class to be FDA approved. | A class of drugs that target one or more components of the Hedgehog signaling pathway. Vismodegib is the first in class to be FDA approved. | ||
| − | [[Category: | + | [[Category:Chemotherapeutic]] |
Revision as of 18:06, 3 February 2019
A class of drugs that target one or more components of the Hedgehog signaling pathway. Vismodegib is the first in class to be FDA approved.
Pages in category "Hedgehog pathway inhibitors"
The following 3 pages are in this category, out of 3 total.